MedAvant gets $20 million financing from Laurus Master Fund

By Sheri Kasprzak

New York, Dec. 7 - MedAvant Inc. said it received a $20 million financing from Laurus Master Fund, Ltd.

The full terms of the financing could not be determined Wednesday, but a statement from the company said the details would be revealed in an 8-K filed with the Securities and Exchange Commission.

Atlanta-based MedAvant is a health care technology services company focused on health care transaction processing, medical cost containment services, business process outsourcing and other services to physicians and pharmacists.

ProxyMed, Inc. is MedAvant's parent company and its stock gained a penny on Wednesday to settle at $4.74.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.